ReviewInsects2026
An Updated Checklist of the Phytophagous Ladybird Beetles (Coccinellinae: Epilachnini) of China.
Review in Insects, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
A comprehensive annotated checklist of the members of the phytophagous ladybird beetle tribe Epilachnini (Coccinellinae) in China is compiled based on existing published sources and incorporates the latest taxonomic and nomenclatural updates. The checklist documents 176 extant species across 10 genera and provides analyses of regional species richness, distribution, and host plant associations. Regarding regional species richness, Yunnan Province is home to the highest number of species (76), followed by Taiwan (50), Sichuan (48), Guizhou (48), Guangxi (43), Tibet (43), Guangdong (25), Hainan (17), Hubei (17), Hunan (13), Shaanxi (13), Fujian (12), Henan (10), Jiangsu (10), Anhui (7), Shandong (7), Zhejiang (7), Jiangxi (5), Hong Kong (5), Gansu (5), Beijing (4), Hebei (4), Liaoning (3), Shanxi (2), and Chongqing, Jilin, Heilongjiang, Ningxia, and Xinjiang (each with one species). Among the recognized genera,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.